Knowledge Center
Article / Jun 08, 2009
ËÄÉ«AV Shapes China Manufacturing Site
Source:
C&EN, 8 June, 2009
ËÄÉ«AV may have made itself a name as a first-class manufacturer of regulated active pharmaceutical ingredients (APIs), but it still needs to compete on price for some of its business. As in many industries, one of the best ways to lower cost is to have a manufacturing base in China. That is what ËÄÉ«AV did in March 2008 when it acquired a 75% stake in Hisyn Pharmaceutical, an API manufacturer in Taizhou, Zhejiang province. The site is a four-hour drive from Shanghai.
Related links
Also in the Knowledge Center
/ Feb 02, 2022
Webinar - Process safety evaluation and scale-up resorting to mechanistic modelling for exothermic and gas releasing reactions
Read more
Scientific Article
/ Feb 24, 2022
Webinar - Spray Drying Development: From Lab to Production – How to de-risk your process
Read more
Scientific Article
/ Feb 28, 2023
Webinar - Amorphous Solid Dispersions by Spray Drying: From Early Formulation to Commercial Lifecycle Management
Read more
Scientific Article